Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 353

The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.

Delta-radiomics features for the prediction of patient outcomes in non–small cell lung cancer

Open access
Fave, Xenia, Zhang, Lifei, Yang, Jinzhong, Mackin, Dennis, Balter, Peter, Gomez, Daniel, Followill, David, Jones, Aaron Kyle, Stingo, Francesco, Liao, Zhongxing, Mohan, Radhe, Court, Laurence·2017·Scientific Reports

Abstract

Radiomics is the use of quantitative imaging features extracted from medical images to characterize tumor pathology or heterogeneity. Features measured at pretreatment have successfully predicted patient outcomes in numerous cancer sites. This project was designed to determine whether radiomics features measured from non–small cell lung cancer (NSCLC) change during therapy and whether those features (delta-radiomics features) can improve prognostic models. Features were calculated from pretreatment and weekly intra-treatment computed tomography images for 107 patients with stage III NSCLC. Pretreatment images were used to determine feature-specific image preprocessing. Linear mixed-effects models were used to identify features that changed significantly with dose-fraction. Multivariate models were built for overall survival, distant metastases, and local recurrence using only clinical factors, clinical factors and pretreatment radiomics features, and clinical factors, pretreatment radiomics features, and delta-radiomics features. All of the radiomics features changed significantly during radiation therapy. For overall survival and distant metastases, pretreatment compactness improved the c-index. For local recurrence, pretreatment imaging features were not prognostic, while texture-strength measured at the end of treatment significantly stratified high- and low-risk patients. These results suggest radiomics features change due to radiation therapy and their values at the end of treatment may be indicators of tumor response.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41598-017-00665-z

Cites

50 of 50 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 50 references

Cited by

See all 353

Metadata

Authors
Fave, X., Zhang, L., Yang, J., Mackin, D., Balter, P., Gomez, D., Followill, D., Jones, A. K., Stingo, F., Liao, Z., Mohan, R., & Court, L.
Venue
Scientific Reports
Published
2017-04-03
Volume
7
Issue
1
Pages
588-588
ISSN
2045-2322 (ISSN-L)
OpenAlex
W2599895745
Cited by
353
References
50
FWCI
22.91
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Delta-radiomics features for the prediction of patient outcomes in non–small cell lung cancer. https://app.cochat.ai/papers/10.1038/s41598-017-00665-z
The paper
Fave, X., Zhang, L., Yang, J., Mackin, D., Balter, P., Gomez, D., Followill, D., Jones, A. K., Stingo, F., Liao, Z., Mohan, R., & Court, L. (2017). Delta-radiomics features for the prediction of patient outcomes in non–small cell lung cancer. Scientific Reports. https://doi.org/10.1038/s41598-017-00665-z

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.